Outlook Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Outlook Therapeutics Inc 's inventory turnover ratio sequentially decreased to 0.26 in the third quarter 2026, unsurprisingly, as the Outlook Therapeutics Inc markets continue to deteriorate, and OTLK's faces growing challenges to bring down its inventories. Outlook Therapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 1404 days, from 913 days, in the Mar 31 2026 quarter.

Within Healthcare sector 366 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1614 in the second quarter 2026, to 1899.

OTLK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Outlook Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OTLK Inventory Turnover Ratio	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter
Y / Y Inventory Growth	22.22 %	-7.22 %	-	-	-
Y / Y Cost of Sales Growth	-96.14 %	-	-	-	-
Inventory Turnover Ratio (TTM)	0.26	0.4	0.38	0.49	0.23
OTLK's Total Ranking	# 1899	# 1614	# 1104	# 1826	# 0
Average inventory processing period	1396	917	949	745	1604
Seq. Inventory Growth	50.81 %	0.17 %	0 %	-19.1 %	14.49 %
Seq. Cost of Sales Growth	-22.49 %	-26.12 %	-96.77 %	108.39 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 29
Healthcare Sector	# 367
Overall Market	# 1899

Inventory Turnover Ratio Statistics
High	Average	Low
0.4	0.36	0.26
(Mar 31 2026)		(Jun 30 2026)

OTLK Company Profile >> Back to OTLK Efficiency Comparisons >> Compare OTLK Inventory Turnover Ratio to its Competitors

Financial Statements
Outlook Therapeutics Inc 's Inventories	$ 5 Millions	Visit OTLK's Balance sheet
Outlook Therapeutics Inc 's Cost of Revenues TTM	$ 1 Millions	Visit OTLK's Income Statement
What are OTLK's Sales?		Visit OTLK's Sales by Segment

Other Inventory Turnover Ratios
Outlook Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
OTLK's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for OTLK's Competitors
Inventory Turnover Ratio for OTLK's Suppliers
Inventory Turnover Ratio for OTLK's Customers

You may also want to know
OTLK's Sales Growth Rates	OTLK's Pe Price to earnings ratio	OTLK's Receivables Turnover Ratio	OTLK's Stock Quote
OTLK's Net Income Growth Rates	OTLK's Ps Price to Sales ratio	OTLK's Sales per Employee	OTLK's Asset Turnover Ratio
OTLK's Net Margin	OTLK's Pb Price to Book ratio	OTLK's Financial Strength Ratios	OTLK's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Ionis Pharmaceuticals Inc	0.53	$ 9.873 Millions	$ 19 Millions
Heron Therapeutics Inc	0.53	$ 45.572 Millions	$ 86 Millions
Orchestra Biomed Holdings Inc	0.52	$ 0.157 Millions	$ 0 Millions
Sintx Technologies Inc	0.51	$ 0.627 Millions	$ 1 Millions
Siga Technologies Inc	0.50	$ 24.494 Millions	$ 49 Millions
Ardelyx inc	0.50	$ 25.401 Millions	$ 51 Millions
Regeneron Pharmaceuticals Inc	0.49	$ 1,549.600 Millions	$ 3,161 Millions
Orthopediatrics Corp	0.49	$ 65.142 Millions	$ 134 Millions
Scienture Holdings Inc	0.47	$ 0.101 Millions	$ 0 Millions
Co diagnostics Inc	0.44	$ 0.412 Millions	$ 1 Millions
Immunitybio inc	0.43	$ 1.095 Millions	$ 3 Millions
Pelthos Therapeutics Inc	0.40	$ 9.271 Millions	$ 23 Millions
EBR Systems, Inc.	0.39	$ 5.514 Millions	$ 14 Millions
Aspire Biopharma Holdings Inc	0.34	$ 0.080 Millions	$ 0 Millions
Guided Therapeutics Inc	0.32	$ 0.158 Millions	$ 1 Millions
Invo Fertility Inc	0.29	$ 0.065 Millions	$ 0 Millions
Outlook Therapeutics Inc	0.26	$ 0.985 Millions	$ 4 Millions
Agios Pharmaceuticals Inc	0.23	$ 7.873 Millions	$ 34 Millions
Alpha Cognition Inc.	0.23	$ 1.250 Millions	$ 6 Millions
Verrica Pharmaceuticals Inc	0.17	$ 0.400 Millions	$ 2 Millions
Nexalin Technology Inc	0.17	$ 0.030 Millions	$ 0 Millions
Femasys Inc	0.15	$ 0.898 Millions	$ 6 Millions
Yubo International Biotech Limited	0.15	$ 0.004 Millions	$ 0 Millions
Bioadaptives Inc	0.14	$ 0.006 Millions	$ 0 Millions
Madrigal Pharmaceuticals Inc	0.12	$ 10.400 Millions	$ 89 Millions
Citius Pharmaceuticals Inc	0.07	$ 1.610 Millions	$ 22 Millions
Ptc Therapeutics inc	0.05	$ 3.600 Millions	$ 75 Millions
Adagio Medical Holdings inc	0.05	$ 0.089 Millions	$ 2 Millions

Date modified: 2026-08-29T17:35:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.